Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chloroprocaine is an ester-type local anesthetic primarily used for the production of local or regional anesthesia, including infiltration, peripheral nerve block, epidural, caudal, and subarachnoid (spinal) anesthesia in adults. It acts by binding to the alpha subunit on the cytoplasmic region of voltage-gated sodium channels in neuronal cell membranes, inhibiting sodium influx and thereby blocking nerve impulse conduction. This results in a reversible loss of sensation with a rapid onset (6–12 minutes) and short duration of action (up to 60 minutes). Chloroprocaine is especially favored for procedures requiring quick onset and short duration of anesthesia. At therapeutic doses it has minimal cardiovascular effects but can cause central nervous system stimulation or depression at toxic concentrations[2][3][4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chloroprocaine.